Product Information
CLOZAPINE ODT 150 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $14.9708 per EA under NDC 59651026301. Its NADAC has been published 36 times since Jan 28, 2026.
FDA first approved this application on Dec 12, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651026301
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLOZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA212923FDA Approved
12/12/2024
TE Code
AB
On Market Since
12/12/2024
Pharmacological Classes
Price Statistics
The NADAC for CLOZAPINE ODT 150 MG TABLET has been published 36 times since Jan 28, 2026, and over the history we have for it it has risen 5.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.9708 per EA |
|---|---|
| All-time high | $14.9708 (Sep 30, 2026) |
| All-time low | $14.1802 (May 20, 2026) |
| 52-week high | $14.9708 |
| 52-week low | $14.1802 |
| Median price | $14.2458 |
| Average price | $14.4537 |
| Largest weekly change | +2.9% (Aug 19, 2026) |
| Weeks tracked | 36 |
| Tracking since | Jan 28, 2026 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clozapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOZAPINE ODT 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLOZAPINE ODT 150 MG TABLET, manufactured by Aurobindo Pharma Limited, is $14.9708 per EA (NDC 59651026301), effective Sep 30, 2026.
How has the price of CLOZAPINE ODT 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLOZAPINE ODT 150 MG TABLET has risen 5.1%. It has been tracked across 36 weekly CMS publications since Jan 28, 2026.
What are the highest and lowest recorded NADAC prices for CLOZAPINE ODT 150 MG TABLET?
Since Jan 28, 2026, the NADAC for CLOZAPINE ODT 150 MG TABLET has ranged from a low of $14.1802 (May 20, 2026) to a high of $14.9708 (Sep 30, 2026), with a median of $14.2458 per EA.
Are there cheaper alternatives to CLOZAPINE ODT 150 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CLOZAPINE ODT 150 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOZAPINE ODT 150 MG TABLET?
CLOZAPINE ODT 150 MG TABLET (NDC 59651026301) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.